Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Penumbra Inc (PEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,709,029
  • Shares Outstanding, K 34,380
  • Annual Sales, $ 333,760 K
  • Annual Income, $ 4,660 K
  • 36-Month Beta 0.08
  • Price/Sales 14.51
  • Price/Cash Flow 1,145.99
  • Price/Book 11.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.00
  • Number of Estimates 2
  • High Estimate 0.03
  • Low Estimate -0.04
  • Prior Year 0.01
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
129.20 +5.88%
on 10/11/18
156.20 -12.42%
on 09/26/18
-12.55 (-8.40%)
since 09/21/18
3-Month
118.60 +15.35%
on 08/15/18
158.70 -13.80%
on 09/17/18
-0.45 (-0.33%)
since 07/20/18
52-Week
82.55 +65.72%
on 01/08/18
167.35 -18.26%
on 06/01/18
+41.25 (+43.17%)
since 10/20/17

Most Recent Stories

More News
Is Penumbra (PEN) Stock Outpacing Its Medical Peers This Year?

Is (PEN) Outperforming Other Medical Stocks This Year?

PEN : 136.80 (-0.12%)
Analysis: Positioning to Benefit within Penumbra, Aetna, Littelfuse, IHS Markit, Credit Acceptance, and Insulet -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Penumbra, Inc. (NYSE:PEN),...

AET : 199.49 (-0.35%)
CACC : 404.71 (-3.21%)
PEN : 136.80 (-0.12%)
PODD : 88.10 (-0.10%)
LFUS : 177.56 (+1.31%)
INFO : 51.84 (-0.40%)
Penumbra (PEN) Stock Moves -1.17%: What You Should Know

Penumbra (PEN) closed at $140.68 in the latest trading session, marking a -1.17% move from the prior day.

PEN : 136.80 (-0.12%)
Penumbra, Inc. Schedules Third Quarter 2018 Earnings Release and Conference Call for November 5, 2018

Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2018 after market close on Monday, November 5, 2018 at 5:00 PM Eastern...

PEN : 136.80 (-0.12%)
Penumbra (PEN) Stock Moves -1.9%: What You Should Know

Penumbra (PEN) closed at $131 in the latest trading session, marking a -1.9% move from the prior day.

PEN : 136.80 (-0.12%)
Top Stock Picks for the Week of October 8th

Two Technology Companies With Different Focus.

MSFT : 109.63 (+0.89%)
PEN : 136.80 (-0.12%)
Late Rally Ends the Dow's Slump

Late Rally Ends the Dow's Slump

TGT : 83.23 (+1.48%)
CVS : 72.84 (-1.81%)
TJX : 108.65 (+1.30%)
DG : 110.02 (+0.43%)
HK : 3.85 (-3.27%)
CI : 208.80 (-0.57%)
ILMN : 317.23 (+1.32%)
MOH : 134.08 (-0.36%)
VOYA : 45.27 (-2.96%)
KSS : 73.02 (+2.47%)
TSCO : 87.39 (+0.61%)
NTR : 54.58 (-2.26%)
URI : 114.91 (-1.89%)
HTZ : 15.17 (-0.78%)
PFG : 52.54 (-1.90%)
TMUS : 69.51 (-0.34%)
AOBC : 13.91 (unch)
WBA : 77.65 (+0.39%)
PEN : 136.80 (-0.12%)
SFM : 27.41 (-0.18%)
CLF : 11.34 (+2.62%)
SDOW : 16.14 (+1.51%)
Accelerate Diagnostics (AXDX) Surges: Stock Moves 6% Higher

Accelerate Diagnostics (AXDX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

AXDX : 16.04 (-4.12%)
PEN : 136.80 (-0.12%)
Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel

Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel

EW : 149.31 (+2.68%)
PEN : 136.80 (-0.12%)
BEAT : 54.20 (+1.06%)
VCEL : 11.29 (-0.35%)
ISRG : 511.41 (+1.42%)
How to Invest in the Hot Medical Device Innovators

Forget the biotechs. Medical device companies are innovating in amazing ways. Here's how to invest.

EW : 149.31 (+2.68%)
PEN : 136.80 (-0.12%)
BEAT : 54.20 (+1.06%)
VCEL : 11.29 (-0.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade PEN with:

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

2nd Resistance Point 141.69
1st Resistance Point 139.25
Last Price 136.80
1st Support Level 134.33
2nd Support Level 131.85

See More

52-Week High 167.35
Last Price 136.80
Fibonacci 61.8% 134.96
Fibonacci 50% 124.95
Fibonacci 38.2% 114.94
52-Week Low 82.55

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar